Investor News and Announcements
Sunshine Heart is a global medical technology company, committed to the commercialization of C-Pulse®, an implantable, non-blood contacting, heart assist therapy for the treatment of people with class III and ambulatory class IV heart failure. Sunshine Heart is listed on the NASDAQ and the Australian Securities Exchange (ASX).
April 2013
ASX - Sunshine Heart Suspension from Official Quotation
April 2013
Sunshine Heart, Inc. Closes Public Offering of Common Shares
April 2013
Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares
April 2013
Sunshine Heart, Inc. Announces Proposed Public Offering of Common Shares
April 2013
Corporate Presentation
April 2013
Sunshine Heart Announces Donal O’Dwyer Will Retire From Board of Directors
March 2013
Sunshine Heart Appoints Jon Salveson to Board of Directors
March 2013
Sunshine Heart Reports Fourth Quarter and Full Year 2012 Results
February 2013
ASX Grants Conditional Approval to Delist
February 2013
Sunshine Heart – Delisting from Australian Securities Exchange
January 2013
Sunshine Heart to Delist from the Australian Securities Exchange
January 2013
Sunshine Heart Appoints Warren Watson to Board of Directors
January 2013
Sunshine Heart Enters Into a $25 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
January 2013
US Clinical Update
November 2012
Sunshine Heart TCT Presentation
November 12, 2012
Sunshine Heart 3Q12 Report
November 9, 2012
Sunshine Heart Announces 3Q12 Financial Results
November 8, 2012
Sunshine Heart to Present at Upcoming Investor Conferences
September 13, 2012
Sunshine Heart Appoints John Erb to Chairman of the Board
August 15, 2012
Sunshine Heart Announces Closing of Public Offering of Common Stock
August 13, 2012
Sunshine Heart Announces $20.125M Public Raise
July 31, 2012
Sunshine Heart Announces 2Q12 Financial Results
July 27, 2012
Annual Meeting Invitation to Stockholders
July 27, 2012
Annual Report 2011
May 14, 2012
Sunshine Heart Provides Revised FAQ Regarding Transmutation of CDIs to Common Stock
May 14, 2012
Quarterly Financial Report on Form 10-Q
May 11, 2012
Sunshine Heart Announces 1Q12 Financial Results
March 8, 2012
Trading on Sunshine Heart FAQ
March 5, 2012
Sunshine Heart CEO to ring NASDAQ closing bell
February 16, 2012
Sunshine Heart Announces NASDAQ Listing
February 16, 2012
Converting CDIs listed on ASX to shares of common stock listed on Nasdaq
February 9, 2012
Sunshine Heart Completes $2.1 Million Private Placement in Anticipation of NASDAQ Listing
January 30, 2012
ASX Circular Reverse U.S Common Stock-Split – Number Split Of Australian CDIS
January 30, 2012
Reverse U.S. Common Stock Split - No Split of Australian CDIs
December 5, 2011
ASX listing rule waivers
December 5, 2011
Annual General Meeting 2011 Presentation
December 5, 2011
Sunshine Heart to Present at The Canaccord Genuity Cardiovascular, Aesthetics and Metabolic Disorders Conference
December 5, 2011
Chief Executive Officer’s Annual General Meeting Update
November 23, 2011
Sunshine Heart to Present at The Piper Jaffray Healthcare Conference
October 4, 2011
Form 10 Registration Statement
October 4, 2011
Change to financial year end
September 5, 2011
Two-part financing strategy supporting C-Pulse® Heart Assist System
August 10, 2011
RBS Morgans - Sunshine Heart Positioning for next step
July 25, 2011
Sunshine Heart Completes A$4.6 Million Private Placement in U.S. and Canada
June 9, 2011
Sunshine Heart Completes Feasibility Study for Fully-Implantable
C-Pulse® Heart Assist System
June 22, 2011
Appendix 3B - New Issue Announcement
May 23, 2011
Appendix 3B - New Issue Announcement
May 19, 2011
ASX Announcement - Director Resignation
May 18, 2011
Appointment of CFO and Company Secretary
May 11, 2011
ASX Query Regarding Stock Price Change
May 9, 2011
Appendix 3B - New issue announcement
April 27, 2011
Appendix 4C - Quarterly report
April 11, 2011
Approval to Expand C-Pulse® Heart Assist System Study
February 22, 2011
Appendix 3B - New Issue Announcement
January 31, 2011
Sunshine Heart Appoints New US Board Member
January 25, 2011
Appendix 4C - Quarterly Report
January 25, 2011
Appendix 4D - Half-Year Report
Frequently Asked Questions
Letter to CDI Holders - delisting ASX Trading on Sunshine Heart FAQ Common to CDI Transmutation Form CDI to Common Transmutation FormAnnual Reports
2012 Annual Report 2011 Interactive Annual Report 2011 Annual Report (pdf) Annual Report for year ended December 31, 2011Quarterly Reports
2012 First Quarter Report2012 Second Quarter Report2012 Third Quarter Report